PUFFClicker3 is a universal smart inhaler tracker designed to enhance adherence across all age groups. Compatible with both dry powder and metered dose inhalers (101 SNOMED coded inhalers supported), its interactive touchscreen displays in 16 languages, ensuring accessibility for all users.
Dexter is a respiratory and general medicine doctor, coming to the end of his registrar training in October 2023, when he will be transitioning into a consultant role.
PMD Solutions is revolutionising respiratory outcomes by making every breath count with its novel continuous respiratory rate wearable solutions.
Akara helps hospitals maximise operational efficiency using innovative technologies that increases room utilization, enhances environmental hygiene, and improves environmental sustainability.
Aide is a digital health service that helps patients and clinicians better understand and manage long-term conditions.
By asking the right questions we help patients get the right care from the right caregiver at the right time in the most productive and cost-efficient way.
The Hippo Recaller streamlines and automates GP Practice proactive care processes to help them more efficiently and effectively look after their patient populations.
Remote monitoring for Cystic Fibrosis in children at Addenbrooke’s Hospital, Cambridge, UK with satellite sites at Ipswich Hospital and Peterborough City Hospital.
Tiny Medical Apps’ flagship product, the Digital Health Passport, is an NHS Login enabled Personal Health Record app designed to help patients improve their management of long-term conditions, starting with asthma.
Shereen is a Pharmacist who is currently working as part of the Cystic Fibrosis (CF) digital implementation team and is in the process of developing a self-monitoring app for their patients.
Amelia is a pharmacist who has worked at the Royal Brompton & Harefield NHS Foundation Trust since 2011, is deploying an inpatient prescribing system (MedChart) to outpatient areas.
Robert Sweeney, Business Development, Greenwich Health Limited, is piloting a smoking cessation mobile application.
Yasmine Korimbux, NEL Commissioning Support Unit Senior Prescribing Advisor, Tower Hamlets CCG, is working on a proactive approach to prioritising medication review.
Claire Edmonson, Paediatric Registrar, Imperial College London/Royal Brompton Hospital, is developing a mobile app for home monitoring of young people with Cystic Fibrosis.
Helen Parrott, Associate Director of Rehabilitation and Therapies, Royal Brompton and Harefield NHS Trust, is building a digital platform sharing health data for people with cystic fibrosis and healthcare teams.
Vikram Palit, Paediatrician, Clinical Innovation and Improvement Fellow, Chelsea and Westminster NHS Foundation Trust is digitising paediatric allergy and asthma pathways.
patientMpower provides digital care solutions across a range of pulmonary conditions, including Interstitial Lung Disease (inc pulmonary fibrosis), cystic fibrosis, lung transplant and COVID-19.
Smoke Free is a smoking cessation app that adheres to NICE guidance, implements best practice and has been proven effective in two randomised trials.
Quit Genius is the world’s first technology-enabled digital clinic for multiple addictions. Quit Genius’ digital clinic model allows employees and health plan members to access a proven treatment program 100% remotely.
SIME is a Clinical AI company applying medical excellence, proprietary AI and data ingenuity to deliver rapid respiratory intensive care diagnostics for acute unmet needs.
Inhealthcare delivers remote home monitoring solutions to more than 1,000,000 UK citizens across almost every clinical setting. Their digital health technology supports vulnerable high-risk patients, including those in care homes, and patients living with long-term conditions such as diabetes, COPD, COVID-19 and heart failure.
Digital health and behavioural science company specialising in addictive behaviour. Products include computer-assisted therapy, internet-based interventions for substance-involved offenders in prisons and public health interventions that address smoking and problem drinking on a population-wide scale.